It is a broadly described annual report of Orion Pharma Limited in the year of 2012. In the year end 31st December 2012, Orion Pharma Ltd. has earned revenue of BDT 1,709.41 million. During the financial year, The Company’s Total Net Turnover Taka. 9,546,322,718 million. Gross Profit Taka. 3,046,459,570 million. Net Profit before tax Taka. 1,287,737,341 million. Net Profit after Tax for the year Taka. 933,039,577 million.
The Board of Directors is pleased to propose and recommend for the declaration of Cash Dividend at the rate of @20% for the year 2012. The recommended dividend will involve a cash outflow of Tk.390 million. The Board also proposed a declaration of Stock Dividend (Bonus Shares) at the rate of @20%. These financial statements are presented in Bangladesh Taka (Taka/Tk/BDT) which is the company’s functional currency. All financial information presented in Taka has been rounded off to the nearest Taka.
More Annual Report of Orion Pharma Limited:
